topiramate and tirzepatide together 📢 ACP Obesity Guidelines 2026 are here. For the first time, semaglutide are recommended as co-first-line pharmacotherapy for obesity. #ACPGuidelines #ObesityMedicine #Semaglutide 🥇 THE NEW 4-TIER LADDER Tier 1: 💉 What is the evidence regarding

In our fast-paced and ever-evolving cardiovascular care landscape, breakthroughs like the Watchman Implant are changing the game, offering new hope to those grappling with NVAFiba heart condition notorious for increasing the risk of stroke

Legal and regulatory issues with unlicensed providers: Unlicensed compounding pharmacies may not follow legal and regulatory standards which can be potentially unsafe and harmful

Taking very low doses may not provide the same results

The move comes after an increase in reports of acute pancreatitis to the Medicines and Healthcare products Regulatory Agencys (MHRA) Yellow Card scheme, which monitors any adverse reactions to medications and medical devices in the UK